LIQUIDIA TECHNOLOGIES INC
NASDAQ: LQDA (Liquidia Corporation)
Last update: 5 hours ago80.89
3.81 (4.94%)
| Previous Close | 77.08 |
| Open | 78.70 |
| Volume | 1,069,859 |
| Avg. Volume (3M) | 1,887,185 |
| Market Cap | 7,193,393,664 |
| Price / Earnings (TTM) | 475.82 |
| Price / Earnings (Forward) | 19.42 |
| Price / Sales | 24.09 |
| Price / Book | 63.13 |
| 52 Weeks Range | |
| Earnings Date | 12 Aug 2026 |
| Operating Margin (TTM) | -1,135.42% |
| Diluted EPS (TTM) | -1.71 |
| Quarterly Revenue Growth (YOY) | 5.00% |
| Total Debt/Equity (MRQ) | 297.04% |
| Current Ratio (MRQ) | 2.93 |
| Operating Cash Flow (TTM) | -99.23 M |
| Levered Free Cash Flow (TTM) | -64.38 M |
| Return on Assets (TTM) | -37.66% |
| Return on Equity (TTM) | -203.98% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Bullish |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Liquidia Corporation | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | -4.0 |
| Price Volatility | -3.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 0.5 |
| Average | -1.25 |
|
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Core |
| % Held by Insiders | 13.64% |
| % Held by Institutions | 65.04% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Farallon Capital Management, L.L.C. | 31 Mar 2026 | 8,656,038 |
| Caligan Partners Lp | 31 Mar 2026 | 8,118,892 |
| Findell Capital Management Llc | 31 Mar 2026 | 3,502,112 |
| Opaleye Management Inc. | 31 Mar 2026 | 2,545,000 |
| Mpm Bioimpact Llc | 31 Mar 2026 | 1,405,158 |
| Caprock Group, Llc | 31 Mar 2026 | 1,367,235 |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| ADAIR JASON | - | 71.21 | -7,863 | -559,924 |
| BLOCH STEPHEN M | - | 81.23 | -50,000 | -4,061,500 |
| BOYLE DANA | - | 71.21 | -9,002 | -641,032 |
| JEFFS ROGER | - | 71.21 | -35,249 | -2,510,081 |
| KASETA MICHAEL | - | 71.21 | -20,430 | -1,454,820 |
| KHINDRI SANJEEV | - | 71.21 | -1,185 | -84,384 |
| KREPP SARAH | - | 71.21 | -7,864 | -559,995 |
| MOOMAW SCOTT | - | 71.21 | -9,539 | -679,272 |
| SAGGAR RAJEEV | - | 71.21 | -9,926 | -706,830 |
| SCHUNDLER RUSSELL | - | 71.21 | -14,738 | -1,049,493 |
| Aggregate Net Quantity | -165,796 | |||
| Aggregate Net Value ($) | -12,307,333 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 72.21 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| BOYLE DANA | Officer | 13 Jul 2026 | Automatic sell (-) | 9,002 | 71.21 | 641,032 |
| MOOMAW SCOTT | Officer | 13 Jul 2026 | Automatic sell (-) | 9,539 | 71.21 | 679,272 |
| SAGGAR RAJEEV | Officer | 13 Jul 2026 | Automatic sell (-) | 9,926 | 71.21 | 706,830 |
| SCHUNDLER RUSSELL | Officer | 13 Jul 2026 | Automatic sell (-) | 14,738 | 71.21 | 1,049,493 |
| ADAIR JASON | Officer | 13 Jul 2026 | Automatic sell (-) | 7,863 | 71.21 | 559,924 |
| JEFFS ROGER | Officer | 13 Jul 2026 | Automatic sell (-) | 35,249 | 71.21 | 2,510,081 |
| KASETA MICHAEL | Officer | 13 Jul 2026 | Automatic sell (-) | 20,430 | 71.21 | 1,454,820 |
| KHINDRI SANJEEV | Officer | 13 Jul 2026 | Automatic sell (-) | 1,185 | 71.21 | 84,384 |
| KREPP SARAH | Officer | 13 Jul 2026 | Automatic sell (-) | 7,864 | 71.21 | 559,995 |
| BOYLE DANA | Officer | 10 Jul 2026 | Option execute | 3,179 | - | - |
| MOOMAW SCOTT | Officer | 10 Jul 2026 | Option execute | 7,466 | - | - |
| SAGGAR RAJEEV | Officer | 10 Jul 2026 | Option execute | 8,018 | - | - |
| SCHUNDLER RUSSELL | Officer | 10 Jul 2026 | Option execute | 10,168 | - | - |
| ADAIR JASON | Officer | 10 Jul 2026 | Option execute | 10,251 | - | - |
| JEFFS ROGER | Officer | 10 Jul 2026 | Option execute | 28,167 | - | - |
| KASETA MICHAEL | Officer | 10 Jul 2026 | Option execute | 12,879 | - | - |
| KREPP SARAH | Officer | 10 Jul 2026 | Option execute | 3,179 | - | - |
| BLOCH STEPHEN M | Director | 07 Jul 2026 | Sell (-) | 50,000 | 81.23 | 4,061,500 |
| Show more | ||||||
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |